121 related articles for article (PubMed ID: 17913459)
1. Structural domains determining signalling characteristics of the CRH-receptor type 1 variant R1beta and response to PKC phosphorylation.
Teli T; Markovic D; Hewitt ME; Levine MA; Hillhouse EW; Grammatopoulos DK
Cell Signal; 2008 Jan; 20(1):40-9. PubMed ID: 17913459
[TBL] [Abstract][Full Text] [Related]
2. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation.
Markovic D; Papadopoulou N; Teli T; Randeva H; Levine MA; Hillhouse EW; Grammatopoulos DK
J Pharmacol Exp Ther; 2006 Dec; 319(3):1032-42. PubMed ID: 16956982
[TBL] [Abstract][Full Text] [Related]
3. Characterization of structural determinants of type 1 corticotropin releasing hormone (CRH) receptor signalling properties.
Markovic D; Grammatopoulos DK
Methods Mol Biol; 2010; 634():285-307. PubMed ID: 20676992
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone.
Karteris E; Markovic D; Chen J; Hillhouse EW; Grammatopoulos DK
Endocrinology; 2010 Oct; 151(10):4959-68. PubMed ID: 20702571
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.
Markovic D; Lehnert H; Levine MA; Grammatopoulos DK
Mol Endocrinol; 2008 Nov; 22(11):2505-19. PubMed ID: 18772229
[TBL] [Abstract][Full Text] [Related]
6. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization.
Teli T; Markovic D; Levine MA; Hillhouse EW; Grammatopoulos DK
Mol Endocrinol; 2005 Feb; 19(2):474-90. PubMed ID: 15498832
[TBL] [Abstract][Full Text] [Related]
7. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.
Papadopoulou N; Chen J; Randeva HS; Levine MA; Hillhouse EW; Grammatopoulos DK
Mol Endocrinol; 2004 Mar; 18(3):624-39. PubMed ID: 14657255
[TBL] [Abstract][Full Text] [Related]
9. A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.
Grammatopoulos DK; Dai Y; Randeva HS; Levine MA; Karteris E; Easton AJ; Hillhouse EW
Mol Endocrinol; 1999 Dec; 13(12):2189-202. PubMed ID: 10598591
[TBL] [Abstract][Full Text] [Related]
10. Differential desensitization of dopamine D2 receptor isoforms by protein kinase C: the importance of receptor phosphorylation and pseudosubstrate sites.
Morris SJ; Van-Ham II; Daigle M; Robillard L; Sajedi N; Albert PR
Eur J Pharmacol; 2007 Dec; 577(1-3):44-53. PubMed ID: 17869243
[TBL] [Abstract][Full Text] [Related]
11. Serine 331 is major site of phosphorylation and desensitization induced by protein kinase C in thromboxane receptor alpha.
Yan FX; Yamamoto S; Zhou HP; Tai HH; Liao DF
Acta Pharmacol Sin; 2002 Oct; 23(10):952-60. PubMed ID: 12370102
[TBL] [Abstract][Full Text] [Related]
12. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
[TBL] [Abstract][Full Text] [Related]
13. Identification of protein kinase C phosphorylation sites involved in phorbol ester-induced desensitization of the histamine H1 receptor.
Fujimoto K; Ohta K; Kangawa K; Kikkawa U; Ogino S; Fukui H
Mol Pharmacol; 1999 Apr; 55(4):735-42. PubMed ID: 10101032
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of Galpha11 protein contributes to agonist-induced desensitization of 5-HT2A receptor signaling.
Shi J; Zemaitaitis B; Muma NA
Mol Pharmacol; 2007 Jan; 71(1):303-13. PubMed ID: 17056873
[TBL] [Abstract][Full Text] [Related]
15. Engineered G protein coupled receptors reveal independent regulation of internalization, desensitization and acute signaling.
Scearce-Levie K; Lieberman MD; Elliott HH; Conklin BR
BMC Biol; 2005 Feb; 3():3. PubMed ID: 15707483
[TBL] [Abstract][Full Text] [Related]
16. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression.
Pisarchik A; Slominski AT
FASEB J; 2001 Dec; 15(14):2754-6. PubMed ID: 11606483
[TBL] [Abstract][Full Text] [Related]
18. The role of helix 8 and of the cytosolic C-termini in the internalization and signal transduction of B(1) and B(2) bradykinin receptors.
Faussner A; Bauer A; Kalatskaya I; Schüssler S; Seidl C; Proud D; Jochum M
FEBS J; 2005 Jan; 272(1):129-40. PubMed ID: 15634338
[TBL] [Abstract][Full Text] [Related]
19. Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptor.
Punn A; Chen J; Delidaki M; Tang J; Liapakis G; Lehnert H; Levine MA; Grammatopoulos DK
J Biol Chem; 2012 Mar; 287(12):8974-85. PubMed ID: 22247544
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the alternatively spliced insert region of the D2L dopamine receptor by epitope substitution.
Kendall RT; Senogles SE
Neurosci Lett; 2006 Jan; 393(2-3):155-9. PubMed ID: 16226376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
